SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-003099
Filing Date
2014-08-04
Accepted
2014-08-04 17:05:04
Documents
12
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ctic-10q_20140630.htm 10-Q 1321712
2 EX-10.1 ctic-ex10_20140630363.htm EX-10 229423
3 EX-15 ctic-ex15_20140630183.htm EX-15 3266
4 EX-31.1 ctic-ex31_201406306.htm EX-31 11024
5 EX-31.2 ctic-ex31_201406307.htm EX-31 11930
6 EX-32 ctic-ex32_201406308.htm EX-32 12294
  Complete submission text file 0001564590-14-003099.txt   4016604

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ctic-20140630.xml EX-101.INS 355233
8 XBRL TAXONOMY EXTENSION SCHEMA ctic-20140630.xsd EX-101.SCH 22493
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctic-20140630_cal.xml EX-101.CAL 38947
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctic-20140630_def.xml EX-101.DEF 151263
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctic-20140630_lab.xml EX-101.LAB 205963
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctic-20140630_pre.xml EX-101.PRE 174479
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12465 | Film No.: 141013691
SIC: 2834 Pharmaceutical Preparations